Urologic Bacteriome: The Hero or the Villain in Prostate Cancer Onset, Progression, and Treatment?
ABSTRACT Prostate cancer (PCa) is the second most frequently diagnosed cancer in men worldwide and the fifth leading cause of cancer‐related mortality, presenting urgent unmet clinical needs in diagnosis and treatment. The recognition of the microbiome as a key factor in human health has prompted numerous studies, revealing an exciting new approach to ...
Lara R. S. Fonseca +6 more
wiley +1 more source
Neuropeptide Y drives vitiligo progression via NPYR-mediated NF-κB activation: a novel therapeutic target. [PDF]
Tian B +11 more
europepmc +1 more source
Thymus and Leishmania at the Crossroads: Autoimmunity and Cancer
Conceptual ‘Crossroads Model’ linking Leishmania, thymic infection and immune dysregulation: an integrative model is proposed in which Leishmania infection disrupts thymic architecture and stromal–thymocyte interactions. These alterations converge to promote defective tolerance, increased autoimmune risk and a microenvironment permissive to malignant ...
Alef Batista Bezerra Barros +5 more
wiley +1 more source
Mechanisms and biomarkers of immune checkpoint inhibitor-associated myocarditis: from T cell imbalance to multicellular crosstalk. [PDF]
Huang J +6 more
europepmc +1 more source
Ovarian hormones and high‐fat diet duration distinctively modulate hypothalamic chemokine profile
Abstract Excessive intake of saturated fats triggers inflammation in the hypothalamus, a key regulator of energy balance. In the chronic phase of this inflammatory response, bone marrow‐derived and lymphoid cells are chemoattracted to this region, partially mitigating high‐fat diet (HFD)‐induced metabolic impairments.
Alexia Guimaraes Batista Augusto +8 more
wiley +1 more source
Comprehensive characterization of the inflammatory ecosystems in immunotherapy-induced adverse events versus chronic inflammatory diseases. [PDF]
Kang J, An J, Choi JK.
europepmc +1 more source
Chemokines CXCL9 and CCL2 in Relation to Cerebral White Matter Disease, Cognitive Decline, and Dementia: The Northern Manhattan Study. [PDF]
Shahrestani MN +8 more
europepmc +1 more source
Development of an improved preclinical humanized mouse platform representing the diverse clinical phenotypes of Sjögren's syndrome. [PDF]
Park JS +7 more
europepmc +1 more source
Divergent roles of serum CXCL9 as a biomarker in ILD and COPD: a comparative study. [PDF]
Yin C +7 more
europepmc +1 more source
Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond. [PDF]
Oechtering J +28 more
europepmc +1 more source

